Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment
- DOI
- 10.1038/s41598-024-78350-1
- Published
- 2024-11-05
- Container
- Scientific Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-024-78350-1,
title = {Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment},
author = {Min Ji Jeon and Eun Sang Yu and Dae Sik Kim and Byung-Hyun Lee and Se Ryeon Lee and Hwa Jung Sung and Chul Won Choi and Yong Park and Byung Soo Kim and Ka-Won Kang},
year = {2024},
journal = {Scientific Reports},
doi = {10.1038/s41598-024-78350-1},
url = {https://doi.org/10.1038/s41598-024-78350-1}
}RIS
TY - JOUR TI - Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment AU - Min Ji Jeon AU - Eun Sang Yu AU - Dae Sik Kim AU - Byung-Hyun Lee AU - Se Ryeon Lee AU - Hwa Jung Sung AU - Chul Won Choi AU - Yong Park AU - Byung Soo Kim AU - Ka-Won Kang PY - 2024 JO - Scientific Reports DO - 10.1038/s41598-024-78350-1 UR - https://doi.org/10.1038/s41598-024-78350-1 ER -
APA
Jeon, M. J., Yu, E. S., Kim, D. S., Lee, B., Lee, S. R., Sung, H. J., Choi, C. W., Park, Y., Kim, B. S., & Kang, K. (2024). Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment. Scientific Reports. https://doi.org/10.1038/s41598-024-78350-1
Source records
- crossref · retrieved 2026-09-25T14:41:37.920Z